Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis
Malgorzata Gozdecka(Wellcome Sanger Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Konstantinos Tzelepis(The Gurdon Institute), Theodoros Georgomanolis(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Pedro M. Quirós(École Polytechnique Fédérale de Lausanne), Vijaya Baskar Mahalingam Shanmugiah(Wellcome/MRC Cambridge Stem Cell Institute), Christian Frezza(TH Köln - University of Applied Sciences), George Giotopoulos(Wellcome/MRC Cambridge Stem Cell Institute), Paolo Gallipoli(Wellcome/MRC Cambridge Stem Cell Institute), James A. Nathan(University of Cambridge), Ludovica Marando(Wellcome/MRC Cambridge Stem Cell Institute), Guinevere L. Grice(University of Cambridge), Rula Bany Bakar(MRC Epidemiology Unit), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Richard J Stopforth(MRC Epidemiology Unit), Aristi Damaskou(Wellcome/MRC Cambridge Stem Cell Institute), Rachael Wilson(Wellcome/MRC Cambridge Stem Cell Institute), Clea Bárcena(Universidad de Oviedo), Justyna Rak(Wellcome/MRC Cambridge Stem Cell Institute), William G. Dunn(Wellcome/MRC Cambridge Stem Cell Institute), Ryan Asby(Wellcome/MRC Cambridge Stem Cell Institute), Penny Wright(Canterbury Health Laboratories), Arthur Kaser(University of Cambridge), Margarete A. Fabre(AstraZeneca (United Kingdom)), Eliza Yankova(University of Cambridge), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Graham Duddy(The Francis Crick Institute), Annalisa Mupo(Wellcome Sanger Institute), Monika Dudek(Wellcome/MRC Cambridge Stem Cell Institute), Siddhartha Kar(At Bristol), Nisha Narayan(Wellcome/MRC Cambridge Stem Cell Institute), Paul Carter(University of Cambridge), Dean C. Pask(Wellcome/MRC Cambridge Stem Cell Institute), Sean Wen(University of Cambridge), Slavé Petrovski(The Royal Melbourne Hospital), Laura Bond(Wellcome/MRC Cambridge Stem Cell Institute), Jonathan Mitchell(AstraZeneca (Australia)), A. Ramesh(Wellcome/MRC Cambridge Stem Cell Institute), Jonathan Cooper(Wellcome Sanger Institute), Sarah J. Horton(Wellcome/MRC Cambridge Stem Cell Institute), Matthew McLoughlin(Wellcome/MRC Cambridge Stem Cell Institute), Kosuke Yusa(Kyoto University)
Cited by 34
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k